AMA Calls for More Women and SGMs in Clinical Trials

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

AMA Calls for More Women and SGMs in Clinical Trials

J.W. Schomisch

June 18, 2024 at 11:09 AM EST

The American Medical Association (AMA) House of Delegates adopted a policy June 11 to ensure more women and sexual and gender minority (SGM) subjects are included in clinical trials. The new policy calls for the AMA to support the FDA in requiring drug and device sponsors to develop actionable clinical trial diversity action plans that include women and SGM populations. The n... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

AMA Calls for More Women and SGMs in Clinical Trials

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT